No Evidence COVID-19 Vaccines Will Block Spread of Coronavirus

No Evidence COVID-19 Vaccines Will Block Spread of Coronavirus

On Nov. 9, 2020, Pfizer, Inc. announced that the experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19 it developed in partnership with Germany’s BioNTech SE had an efficacy rate of 90 percent, based on the results of human clinical trials on the vaccine.1 2 3 This news was followed up a week later with an […]

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]

Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine

Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine

On May 18, 2020, Moderna, Inc. of Cambridge, Massachusetts announced that it had obtained “positive interim clinical data” from a Phase 1 human clinical trial of its experimental mRNA-1273 COVID-19 vaccine that began on Mar. 16. The biotechnology company said that eight of the 45 healthy adult volunteer trial subjects developed antibodies that may provide […]